2021 | 2022 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $1.9B | $2.1B | $2.1B | $1.9B | $1.7B |
Cost of Revenue | $701M | $912M | $912M | $799M | $680M |
Gross Profit | $1.2B | $1.2B | $1.2B | $1.1B | $1B |
Gross Profit % | 62% | 57% | 57% | 58% | 60% |
R&D Expenses | $41M | $62M | $62M | $56M | $45M |
2021 | 2022 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $139M | $37M | $37M | -$15M | -$20M |
Dep. & Amort. | $62M | $67M | $67M | $74M | $66M |
Def. Tax | -$3.6M | -$8.6M | -$8.6M | -$12M | $0 |
Stock Comp. | $22M | $13M | $13M | $15M | $11M |
Chg. in WC | $60M | -$73M | -$73M | -$73M | -$21M |
2021 | 2022 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $4.2M | $1.8M | $1.8M | $2.5M | $2M |
ST Investments | $0 | $0 | $0 | $54M | $0 |
Cash & ST Inv. | $4.2M | $1.8M | $1.8M | $2.5M | $2M |
Receivables | $32M | $26M | $26M | $27M | $18M |
Inventory | $81M | $114M | $114M | $115M | $103M |
Sleep Number reported a challenging 2024 due to weak consumer demand, with net sales declining 11% year-over-year to $1.68 billion and Q4 net sales down 12% to $377 million.
Despite sales declines, the company achieved a 190 basis point improvement in gross margin for the year, reaching 59.6%, driven by material cost reductions, supplier negotiations, and operational efficiencies.
Adjusted EBITDA for 2024 was $120 million, in line with guidance, supported by $88 million in operating cost reductions, double the original target.
The company has implemented contingency plans to protect margins and cash flow amid ongoing macroeconomic pressures, including high interest rates, low housing turnover, and weak consumer sentiment.
Sleep Number is not providing 2025 financial guidance yet due to the CEO transition but highlighted continued cost-saving measures and flexibility in its amended credit agreement to navigate the challenging environment.